Inflammation and Cognitive Aging: What Chronic Inflammation Does to the Brain

Inflammation has become one of those words that can explain almost anything if we allow it to.

Fatigue is blamed on inflammation. Brain fog is blamed on inflammation. Weight gain, joint pain, depression, cardiovascular disease and cognitive decline are all frequently placed under the same umbrella.

There is enough real biology behind the idea to make the subject important. There is also enough ambiguity to make it easy to overstate.

The aging brain is influenced by immune signaling. Microglia change with age. Cardiometabolic disease can create a persistent inflammatory environment. Visceral adipose tissue is biologically active. Vascular inflammation can affect the circulation on which the brain depends. Several inflammatory markers are found at higher concentrations in people with mild cognitive impairment and Alzheimer's disease.

None of that means inflammation is a single disease or that lowering one inflammatory marker prevents dementia.

What Inflammation Actually Means

Inflammation is an immune response, not a diagnosis.

When tissue is injured or the body encounters an infection, immune cells release signaling molecules that help coordinate defense and repair. Blood vessels change permeability. Immune cells move into affected tissue. Cytokines carry information between cells. Once the threat has been addressed, regulatory mechanisms normally help bring the response back down.

That is acute inflammation, and we need it.

The concern in chronic disease is different. Inflammatory signaling may persist at a lower level because the underlying stimulus has not disappeared or because normal immune regulation has changed.

Obesity, insulin resistance, smoking, periodontal disease, autoimmune disorders, chronic infections and other conditions can all contribute. Aging itself also changes immune function.

Reducing every discussion to "inflammation is bad" misses half of the biology. A healthy immune system needs to activate when necessary and resolve appropriately when the job is finished.

Microglia and Neuroinflammation

The brain has its own resident immune cells called microglia.

They are sometimes described as though they sit dormant until something goes wrong. In reality, microglia continuously survey their environment. They participate in synaptic remodeling, remove cellular debris, respond to injury and interact with neurons, astrocytes and blood vessels.

They are part of normal brain physiology.

Aging changes them.

Research increasingly suggests that aging microglia can become less efficient at normal surveillance and debris clearance while some populations become more prone to persistent inflammatory signaling. These changes may influence synapses, white matter and neuronal resilience.

The story is more complicated than "good microglia become bad microglia." Modern single-cell research is identifying multiple microglial states with different metabolic, inflammatory and protective functions. Some responses may be adaptive. Others may become damaging when they persist.

This helps explain why simply suppressing immune activity is unlikely to be a universal answer to cognitive aging. The brain needs a functioning immune system. The goal is healthy regulation, not elimination of inflammation.

What Is Inflammaging?

Inflammaging is a term used to describe the chronic, low-grade inflammatory state that tends to become more common with advancing age.

It is not one laboratory abnormality and it is not inevitable at the same degree in everyone.

Immune-cell aging, cellular senescence, changes in body composition, mitochondrial stress, metabolic disease, altered barrier function and decades of environmental exposure can all contribute to the inflammatory environment seen later in life.

The brain is not isolated from these changes. Peripheral immune signals interact with the cerebral circulation, blood-brain barrier, meninges and cells within the brain itself.

A 2025 perspective in Neuron went so far as to describe immune aging as an important component of brain aging itself. That does not mean we have an established "immune rejuvenation" treatment for cognitive decline. It reflects how much the field has moved away from viewing the brain and immune system as independent compartments.

Visceral Fat, Insulin Resistance and the Brain

One of the most clinically relevant sources of chronic inflammatory signaling is metabolic dysfunction.

Adipose tissue is not simply passive energy storage. Visceral fat, particularly the fat stored around abdominal organs, releases hormones, fatty acids and inflammatory mediators that can affect metabolism throughout the body.

As visceral adiposity increases, insulin resistance frequently develops alongside it. Glucose rises more easily after meals, fasting insulin may increase, triglycerides may rise and liver fat can accumulate. The inflammatory and metabolic pieces reinforce one another.

A 2024 review in Nature Metabolism examined how obesity-related inflammation changes communication between the body and brain. The effects involve several interfaces, including the blood-brain barrier, meninges and glymphatic pathways, as well as immune and metabolic signaling.

This is one reason we do not view cognitive longevity as a separate specialty from metabolic health.

A person may have no neurologic diagnosis and still be accumulating risks that matter to the brain: increasing visceral fat, fasting hyperinsulinemia, hypertension, fatty liver, sleep apnea and declining physical fitness.

Those changes deserve attention long before someone develops dementia.

For the broader metabolic framework, see our Metabolic Health & Insulin Resistance Guide.

The Vascular Connection Is Easy to Underestimate

The brain receives roughly one-fifth of the body's resting oxygen supply despite representing only a small fraction of body mass. Healthy brain function therefore depends heavily on healthy circulation.

Inflammation and vascular disease frequently travel together.

Hypertension, diabetes, smoking, dyslipidemia and insulin resistance can damage the vascular endothelium and accelerate atherosclerosis. Small-vessel disease can affect white matter. Larger-vessel disease can increase stroke risk. Reduced vascular resilience can make the aging brain more vulnerable to other pathology.

This creates an important practical overlap between cardiovascular prevention and cognitive prevention.

ApoB, blood pressure, glucose regulation, physical activity, smoking status and sleep apnea may not sound like "brain tests." They can nevertheless tell us a great deal about the environment in which the brain is aging.

Learn more in our Inflammation and Heart Disease review.

What Does hs-CRP Actually Tell Us?

High-sensitivity C-reactive protein, or hs-CRP, is one of the more useful and more frequently misunderstood inflammatory biomarkers.

CRP is produced primarily by the liver in response to inflammatory signaling, particularly interleukin-6. The high-sensitivity assay allows relatively low concentrations to be measured and has become especially useful in cardiovascular risk assessment.

It is not a brain-specific marker.

An elevated hs-CRP can occur with obesity, infection, autoimmune disease, smoking, tissue injury, periodontal disease and many other conditions. A temporary respiratory infection can raise it. So can an inflammatory flare.

Research does show an association with cognitive disease. A large 2024 meta-analysis of 106 case-control studies involving more than 18,000 people found that CRP, hs-CRP and several cytokines were elevated in Alzheimer's disease compared with healthy controls. A 2025 meta-analysis similarly found differences in several circulating inflammatory markers in Alzheimer's disease.

Those studies do not mean hs-CRP can diagnose Alzheimer's disease.

Prospective evidence is also nuanced. A systematic review of cohort studies found that higher CRP was associated with increased later dementia risk but did not reliably predict general cognitive decline.

That is about where hs-CRP belongs clinically: a useful piece of systemic and vascular risk information, interpreted alongside the rest of the person.

Does Inflammation Cause Brain Fog?

It can contribute. That answer is very different from saying that brain fog proves someone is inflamed.

Systemic illness and inflammatory states can clearly alter attention, energy and cognition. Anyone who has had influenza understands the effect intuitively. Cytokines influence the nervous system and can produce fatigue, reduced motivation and impaired concentration.

Persistent brain fog, however, has a long differential diagnosis.

Sleep deprivation, obstructive sleep apnea, medications, depression, anxiety, menopause symptoms, thyroid dysfunction, anemia, glucose instability, alcohol, post-infectious syndromes and other medical conditions can produce remarkably similar complaints.

This is where broad "neuroinflammation" explanations can become clinically unhelpful. They create an explanation without necessarily identifying the cause.

If cognition is actually changing, objective cognitive testing can also be more informative than relying entirely on how sharp or foggy someone feels on a particular day.

What Can Actually Reduce Inflammatory Burden?

The most useful interventions are usually directed at the source rather than inflammation as an abstract concept.

If visceral adiposity and insulin resistance are present, improving body composition and metabolic health becomes relevant. If someone smokes, stopping matters. If blood pressure is high, treating it matters. If sleep apnea is fragmenting sleep every night, treating the apnea makes more sense than trying to compensate with an anti-inflammatory supplement.

Regular physical activity affects many of these pathways simultaneously. Resistance training helps preserve muscle and insulin sensitivity. Aerobic exercise improves cardiorespiratory fitness and vascular function. Both become increasingly important with age.

A Mediterranean-style dietary pattern built around vegetables, legumes, fruit, nuts, olive oil, fish and minimally processed foods provides another practical foundation. Adequate protein becomes important for maintaining lean mass as people get older.

Sleep deserves equal attention. Chronic sleep disruption can affect glucose regulation, appetite, blood pressure, autonomic activity and inflammatory signaling. Our review of Sleep, the Glymphatic System and Cognitive Aging looks more closely at the brain-health side of sleep.

None of these strategies is novel. That is part of their advantage.

Where Supplements Fit

Supplements can have a role, but they are much easier to sell than the underlying physiology is to fix.

Omega-3 fatty acids are among the better-studied nutritional compounds in cardiovascular and inflammatory biology. Magnesium may be useful when intake or magnesium status is inadequate and has separate relevance to neuronal physiology and sleep. Specific nutrients may also be appropriate when laboratory testing, diet or the clinical situation identifies a need.

They do not replace treatment of hypertension, visceral adiposity, diabetes, sleep apnea or tobacco exposure.

Our updated Magnesium and Brain Function article reviews the evidence surrounding magnesium, memory, sleep and neuroplasticity in more detail.

When supplements are used, we prefer to place them inside a larger strategy rather than treating them as the strategy itself.

How We Put Inflammation Into Clinical Context

At HormoneSynergy®, we do not evaluate cognitive aging by ordering one inflammatory marker and labeling someone inflamed.

We are more interested in the pattern.

What is happening to body composition? Is visceral fat increasing? What does glucose regulation look like? Is fasting insulin elevated? What are blood pressure and ApoB doing? Is hs-CRP persistently elevated or was it measured during an illness? How is the person sleeping? Is there a reason to suspect sleep apnea? Are exercise capacity and muscle mass being maintained? Has cognition objectively changed?

Hormones can also become relevant in the appropriate setting, particularly through menopause and in documented endocrine disorders. They still need to be interpreted alongside vascular, metabolic and neurologic health rather than as a separate explanation for every symptom.

This is the value of longitudinal measurement. A single number can be interesting. A pattern that changes over several years is often much more useful.

Our broader approach is outlined in the Brain Health & Cognitive Longevity framework and the Inflammation and Longevity Medicine guide.

The Bottom Line

Inflammation is part of the biology of aging, but it is not a useful diagnosis by itself.

The immune system and brain communicate throughout life. Aging changes that relationship. Microglia change. Vascular disease matters. Visceral adiposity and insulin resistance can create chronic inflammatory signaling. Sleep, smoking, physical activity and established inflammatory disease can alter the environment further.

The important clinical question is usually not, "How do we suppress inflammation?"

It is, "Why is this person's inflammatory burden elevated, and what can we change?"

That question leads back to metabolism, vascular health, body composition, sleep, movement, nutrition and the underlying medical conditions that deserve treatment in their own right.

Frequently Asked Questions

What is chronic inflammation?

Chronic inflammation refers to persistent or dysregulated immune signaling that continues beyond the normal short-term response to injury or infection. It can occur with metabolic disease, obesity, autoimmune disorders, smoking, chronic infection and other conditions.

What is neuroinflammation?

Neuroinflammation refers to immune and inflammatory activity within the central nervous system. Microglia, astrocytes, neurons, vascular cells and peripheral immune signals can all participate. Neuroinflammation is not adequately diagnosed by a single blood test such as hs-CRP.

Does chronic inflammation cause cognitive decline?

Persistent inflammatory activity is associated with cognitive impairment and several neurodegenerative diseases, but the relationship is complex. Inflammation may contribute to disease, arise in response to disease, or share underlying causes with it. Association does not establish that inflammation alone caused cognitive decline.

Does a high hs-CRP mean I have brain inflammation?

No. hs-CRP is a marker of systemic inflammatory activity and is useful in cardiovascular risk assessment, but it does not directly measure inflammation inside the brain. Infection, obesity, smoking, inflammatory disease and many other factors can raise hs-CRP.

Is hs-CRP associated with dementia?

Several observational studies and meta-analyses have found associations between elevated CRP or hs-CRP and dementia or Alzheimer's disease. The marker is not sufficiently specific to diagnose or predict dementia by itself.

Can visceral fat increase inflammation?

Yes. Visceral adipose tissue is metabolically active and can contribute to inflammatory signaling, insulin resistance and cardiovascular risk. These pathways may also influence long-term brain health.

What are microglia?

Microglia are resident immune cells in the central nervous system. They monitor brain tissue, participate in synaptic remodeling, remove cellular debris and respond to injury. Their function changes with age and in neurologic disease.

Can inflammation cause brain fog?

Inflammatory states can affect energy, attention and cognition, but brain fog is nonspecific. Sleep problems, medications, thyroid disease, anemia, glucose instability, menopause symptoms, mood disorders and many other conditions can produce similar symptoms.

What is inflammaging?

Inflammaging describes the tendency toward persistent low-grade inflammatory activity with advancing age. It reflects changes in immune function, cellular senescence, metabolism, body composition and other age-related processes rather than one specific disease.

Can lowering inflammation prevent Alzheimer's disease?

No intervention has been shown to prevent Alzheimer's disease simply by lowering a general inflammatory marker. Managing established cardiovascular and metabolic risk factors, exercising, avoiding smoking, addressing sleep disorders and maintaining overall health remain more clinically grounded strategies.

Research & References

1. Serna MF, Mosquera M, García-Perdomo HA. Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment: Systematic Review and Meta-Analysis. Neuromolecular Medicine. 2025. PubMed
2. "Let's talk about sex, inflammaging, and cognition, baby": A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease. 2024. PubMed
3. Le Thuc O, et al. Obesity-induced inflammation: connecting the periphery to the brain. Nature Metabolism. 2024. PubMed
4. Shea JM, Villeda SA. Microglia aging in the hippocampus advances through intermediate states that drive activation and cognitive decline. eLife. 2025. PubMed
5. Schwartz M, et al. Chronological versus immunological aging: Immune rejuvenation to arrest cognitive decline. Neuron. 2025. PubMed
6. Peripheral high levels of CRP predict progression from normal cognition to dementia: A systematic review and meta-analysis. PubMed
7. Association of inflammation and cognition in the elderly: A systematic review and meta-analysis. PubMed